Anti-retroviral drugs--implications for dental prescribing.
Many patients with HIV/AIDS are now being treated with two or more drugs to reduce HIV viraemia and boost CD4 T-cell counts. Patients are using these drugs earlier in the course of their disease and so GDPs are likely to encounter them in practice. The drugs have dramatically altered short term prognosis but are potent and have potentially serious drug interactions. Some of these drugs have interactions with drugs used in the dental care setting and this paper sets out to summarise those that are relevant in this area.